Search

HEALTH AFFAIRS AT THE MINISTRY OF NATIONAL GUARD, Saudi Arabia has invited tenders for Dantrolene Sodium 20 Mg Intravenous Powder for Injection. Tender Notice No: JR663321 Deadline: August 1, 2024 [...]

HEALTH AFFAIRS AT THE MINISTRY OF NATIONAL GUARD, Saudi Arabia has invited tenders for J-Sg- Dantrolene Sodium Capsule 100Mg- Jr662034. Tender Notice No: JR662034 Deadline: July 10, 2024 Copyright © [...]

Tenders are invited for call for tender for the supply of dantrolene sodium 25 mg capsules/tablets Call for tender for the supply of dantrolene sodium 25 mg capsules/tablets Procurement type:supplies [...]

AMSTERDAM: Norgine BV has issued the following news release: Norgine B.V. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has [...]

Combined synopsis/solicitation (original): 65--dantrolene sodium f proposed procurement for nsn 6505016531569 dantrolene sodium f: line 0001 qty 3 ui vi deliver to: w05j med maint ops div tobyha by: 0005 [...]

Combined synopsis/solicitation (original): 65--dantrolene sodium f proposed procurement for nsn 6505016531569 dantrolene sodium f: line 0001 qty 3 ui vi deliver to: w05j med maint ops div tobyha by: 0005 [...]

Tenders Are Invited For Loti 1 Dantrolene Sodium Notification Number: Cn/98919/11082023 Limit Fund:107,028.00 Lek Opening Date: 09-11-2023 Ora : 08:00 Closing Date: 20-11-2023 Ora : 10:00 Suspended:Jo Cpv Code:33600000-6 - [...]

Tenders are invited for call for tender for the supply of dantrolene sodium 20mg powder for solution for injection Call for tender for the supply of dantrolene sodium 20mg powder [...]

Tenders Are Invited For Loti 5 Dantrolene Sodium Notification Number: Cn/51165/07112023 Limit Fund:17,838.00 Lek Opening Date: 12-07-2023 No : 13:00 Closing Date: 07-24-2023 No : 13:00 Suspended:Jo Cpv Code:33600000-6 - [...]

Tenders are invited for Loti 5 Dantrolene Sodium Major organization : DIRECTORATE OF BERAT REGIONAL HOSPITAL Address : Tirana Country :Albania Tender notice number : REF-73385-06-22-2023 Notice type : Tender [...]

Tenders Are Invited For Supply of Dantrolene Sodium Major organization : DIRECTORATE OF BERAT REGIONAL HOSPITAL Address : Tirana Country :Albania Tender notice number : REF-73385-06-22-2023 Notice type : Tender [...]

Tenders are invited for cfq021-0538/23 - cpsu6157/2023 - quotation for the supply of dantrolene sodium 25mg capsules/tablets - (accelerated procedure one-time delivery) Quotation for the supply of dantrolene sodium 25mg [...]

Tenders are invited for call for tender for the supply of dantrolene sodium 25 mg capsules/tablets Call for tender for the supply of dantrolene sodium 25 mg capsules/tablets Procurement type: [...]

Combined synopsis/solicitation (original): 65--dantrolene sodium f Proposed procurement for nsn 6505016531569 dantrolene sodium f: line 0001 qty 60 ui vi deliver to: w05j med maint ops div tobyha by: 0005 [...]

Combined Synopsis/Solicitation (Original): 65--dantrolene sodium f Proposed procurement for nsn 6505016531569 dantrolene sodium f: line 0001 qty 3 ui vi deliver to: w05j med maint ops div tobyha by: 0005 [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') today announced that preclinical research on dantrolene sodium was published [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') today announced that preclinical research on dantrolene sodium was published today in the peer-reviewed Journal of Alzheimer's [...]

WOODCLIFF LAKE, N.J: Eagle Pharmaceuticals, Inc. has issued the following news release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle') today announced that the Company has resubmitted its New Drug Application ('NDA') [...]

WOODCLIFF LAKE, N.J: Eagle Pharmaceuticals, Inc. has issued the following news release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle') announced today a new research agreement with NorthShore University HealthSystem in Evanston, [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle') announced today a new research agreement with NorthShore University HealthSystem in Evanston, IL, focused on studying Eagle's RYANODEX([R]) (dantrolene sodium) [...]

2019 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Bioterrorism Week -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') announced that the U.S. Food and [...]

WOODCLIFF LAKE: Eagle Pharmaceuticals, Inc. has issued the following news release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') today announced that the U.S. Food and Drug Administration ('FDA') [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') today announced that the U.S. Food and Drug Administration ('FDA') has granted orphan drug designation (ODD) for [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. ('Eagle' or the 'Company') (Nasdaq: EGRX) today provided an update on the Company's program for RYANODEX(r) [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. ('Eagle' or the 'Company') (Nasdaq: EGRX) today provided an update on the Company's program for RYANODEX([R]) (dantrolene sodium for injectable suspension) for the [...]

Tenders are invited for tender for the supply of dantrolene sodium 20mg injections Dantrolene sodium 20mg powder for reconstitution for intravenous use only, in ampoules/vials. Procurement type: supplies Cft involves:a [...]

NORTHVALE: Elite Pharmaceuticals, Inc. has issued the following press release: Elite Pharmaceuticals, Inc. ('Elite' or the 'Company') (OTCQB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') today announced positive results of its study to evaluate the [...]

-- Statistically significant lower incidence of brain damage compared to control group, demonstrating neuroprotective properties of RYANODEX in treating nerve agent exposure -- -- Statistically significant robust p-values of 0.04 [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new [...]

WOODCLIFF LAKE, N.J: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new patent related to its RYANODEX([R]) product (dantrolene [...]

Eagle Pharmaceuticals reported that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for RYANODEX (dantrolene sodium) for the treatment of organophosphate exposure. According to a [...]

M2 PHARMA-December 18, 2019-Eagle Pharmaceuticals Granted Orphan Drug Designation for Ryanodex for Treatment of Organophosphate Exposure (C)2019 M2 COMMUNICATIONS - The US Food and Drug Administration has granted orphan drug [...]

2019 MAY 20 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or the 'Company') announced positive [...]

M2 PHARMA-May 10, 2019-Eagle Pharmaceuticals Touts Positive Results of a Study Conducted in Partnership with the US (C)2019 M2 COMMUNICATIONS - US-based specialty pharmaceutical company Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new patent [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new patent [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new patent [...]

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new patent [...]

WOODCLIFF LAKE, N.J: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that the Company has been issued a new [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') today announced positive results of an initial study in over 50 rodents to evaluate the neuroprotective effects [...]

M2 PHARMA-August 31, 2018-Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate Ryanodex for Exertional Heat Stroke (C)2018 M2 COMMUNICATIONS - US-based specialty pharmaceutical company [...]

2018 FEB 22 (VerticalNews) -- By a News Reporter-Staff News Editor at Politics & Government Business -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ('Eagle' or 'the Company') announced that the Company [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ: EGRX) today announced that the Company has initiated the rolling submission of its New Drug Application (NDA) and filed [...]

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ:EGRX) today announced that the U.S. Food and Drug Administration ('FDA') has granted Fast Track designation to its RYANODEX[R] (dantrolene [...]

2017 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') announced that the Company has been [...]